Literature DB >> 239718

Parkinson's disease and its chemotherapy.

O Hornykiewicz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 239718     DOI: 10.1016/0006-2952(75)90190-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  15 in total

1.  Progressively disrupted somatodendritic morphology in dopamine neurons in a mouse Parkinson's model.

Authors:  William B Lynch; Christopher W Tschumi; Amanda L Sharpe; Sarah Y Branch; Cang Chen; Guo Ge; Senlin Li; Michael J Beckstead
Journal:  Mov Disord       Date:  2018-11-15       Impact factor: 10.338

Review 2.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

3.  The effects of dopamine, piribedil (ET-495) and its metabolite S-584 on retinal adenylate cyclase.

Authors:  M Schorderet
Journal:  Experientia       Date:  1975-11-15

4.  Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration.

Authors:  Paola Sgadò; Cristina Viaggi; Annalisa Pinna; Cristina Marrone; Francesca Vaglini; Silvia Pontis; Nicola Biagio Mercuri; Micaela Morelli; Giovanni Umberto Corsini
Journal:  Neurotox Res       Date:  2010-11-23       Impact factor: 3.911

5.  Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated.

Authors:  C Cepeda; N A Buchwald; M S Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

6.  Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates.

Authors:  Dali Yin; Francisco E Valles; Massimo S Fiandaca; John Bringas; Francisco Gimenez; Mitchel S Berger; John Forsayeth; Krystof S Bankiewicz
Journal:  Neuroimage       Date:  2009-09-15       Impact factor: 6.556

7.  Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.

Authors:  S Sarre; P Herregodts; D Deleu; A Devrieze; N De Klippel; G Ebinger; Y Michotte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

8.  Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinsonian rat studied with microdialysis.

Authors:  S Sarre; N De Klippel; P Herregodts; G Ebinger; Y Michotte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

9.  Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons.

Authors:  Sarah Y Branch; Ramaswamy Sharma; Michael J Beckstead
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

10.  Effects of amantadine on dopaminergic neurons in discrete regions of the rat brain.

Authors:  K Toide
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.